Acme Generics Profile
Key Indicators
- Authorised Capital ₹ 121.44 Cr
as on 16-11-2024
- Paid Up Capital ₹ 120.10 Cr
as on 16-11-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 65.72 Cr
as on 16-11-2024
- Satisfied Charges ₹ 95.53 Cr
as on 16-11-2024
- Revenue 67.61%
(FY 2023)
- Profit 125.68%
(FY 2023)
- Ebitda 542.68%
(FY 2023)
- Net Worth 18.82%
(FY 2023)
- Total Assets -6.87%
(FY 2023)
About Acme Generics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 121.44 Cr and a paid-up capital of Rs 120.10 Cr.
The company currently has active open charges totaling ₹65.72 Cr. The company has closed loans amounting to ₹95.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Acme Generics Private Limited India is Ginny Uppal as COMPANY SECRETARY. Viral Shah and Vikas Sharma serve as directors at the Company.
- CIN/LLPIN
U24100PB2021PTC056566
- Company No.
043813
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Acme Generics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ginny Uppal  | Company Secretary | 17-Oct-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Viral Shah | Director | 30-Jul-2021 | Current |
| Vikas Sharma | Whole-Time Director | 05-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Acme Generics.
Acme Generics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 67.61% increase. The company also saw a substantial improvement in profitability, with a 125.68% increase in profit. The company's net worth Soared by an impressive increase of 18.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acme Generics?
In 2023, Acme Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Immacule Lifesciences Private LimitedActive 14 years 3 monthsViral Shah, Vikas Sharma and 1 more are mutual person
Acme Formulation Private LimitedActive 20 years 6 monthsViral Shah, Vikas Sharma and 1 more are mutual person
- Ace Testing Solutions Private LimitedActive 15 years 19 days
Viral Shah and Vikas Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Mar 2024 | ₹15.00 Cr | Open |
State Bank Of India Creation Date: 06 Aug 2021 | ₹50.72 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Apr 2022 | ₹10.99 Cr | Satisfied |
How Many Employees Work at Acme Generics?
Acme Generics has a workforce of 1346 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acme Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acme Generics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
